![]() |
|
|
Vol. 27, Issue 12, 1512-1518, December 1999
Departments of Medicinal Chemistry (V.P.H., R.P.R.), and Laboratory
Medicine and Pathology (L.K.H.), University of Minnesota, Minneapolis,
Minnesota
The induction of putative CYP3A isoforms in cultured porcine
hepatocytes was evaluated by measurement of midazolam metabolism, a
model substrate of the CYP3A family. The induction was also studied at
the molecular level by quantitation of mRNA and protein levels, by
Northern blotting and Western blotting, respectively. Pretreatment with
rifampin (50 µM) resulted in a 5.5- to 9-fold higher rate of
midazolam metabolism when compared with control cultures. No induction
was observed when the cultures were pretreated with 50 µM
dexamethasone. A 12-fold increase in the CYP3A mRNA signal (~2.4 kB)
was observed in induced cultures over control cultures. Microsomal
proteins were separated by SDS-polyacrylamide gel
electrophoresis and detected by immunoblotting with a polyclonal antibody raised against human CYP3A4. The immunoblots showed the presence of four bands in microsomes prepared from pig livers, with two
bands (51.5 and 52 kD) that showed intense staining. Microsomes
prepared from a pig pretreated with rifampin showed marked induction of
these two bands. Immunoblotting of microsomes from rifampin-induced
cultures also showed significantly greater intensity than in control
cultures. Our results indicate that rifampin, but not dexamethasone, is
an inducer of midazolam hydroxylase in pig hepatocytes. This induction
may be regulated at the transcriptional level as detected by an
increase in mRNA with a CYP3A oligonucleotide probe. Finally, there
appears to be a multiplicity of the CYP3A isoforms in pig hepatocytes,
similar to that observed in humans and rats.
This article has been cited by other articles:
![]() |
P. Anzenbacher, E. Anzenbacherova, R. Zuber, P. Soucek, F. P. Guengerich, M. J. Myers, D. E. Farrell, K. D. Howard, and J. C. Kawalek Pig and Minipig Cytochromes P450 Drug Metab. Dispos., January 1, 2002; 30(1): 100 - 102. [Full Text] [PDF] |
||||